Purchase Order 75N91018P00736

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $18,781.20 on May 31, 2018, with an ultimate completion date of May 31, 2019. No set-aside was used. Performance takes place in Marshallton, Delaware. The order is for firm fixed price supply of analytical laboratory instruments and associated consumables from Agilent's Customer Service and Sales Division, a manufacturer of gas chromatography-mass spectrometry systems, liquid chromatography-mass...

The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on October 31, 2018, with a firm fixed price of $11,890.80 and an ultimate completion date of October 31, 2019. Place of performance is Marshallton, Delaware. The order procures analytical laboratory instrumentation or associated consumables and maintenance services, consistent with Agilent's core product portfolio of gas chromatography–mass spectrometry systems, liquid chromatography–mass spectrometry...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $10,972.00 on September 8, 2017, with ultimate completion on October 23, 2017. Performance took place in Marshallton, Delaware. The order was firm fixed price with no set-aside. The source does not specify the procurement's scope or originating solicitation.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a reagent kit valued at $16,259.00 on August 26, 2019, with completion by September 18, 2019. Place of performance is Marshallton, Delaware. No set-aside was used. The order was issued on a firm fixed price basis for commercial laboratory consumables, consistent with Agilent's role as a supplier of analytical instrumentation and related supplies to federal research agencies.</p>

<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on February 7, 2014, valued at $4,075.65, with completion by February 28, 2015. Performance occurs at Marshallton, Delaware. The order carries no set-aside designation and uses firm fixed pricing.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $11,998.80 on October 29, 2019, for a maintenance agreement with an ultimate completion date of October 31, 2020. Place of performance is Marshtonlon, Delaware. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,097.50 on May 21, 2021, for biologicals and reagents with an ultimate completion date of June 4, 2021. No set-aside was used. Performance occurs in Marshallton, Delaware. The order is firm fixed price.</p>